A new wave of “America First” industrial policy is reshaping global supply chains. Medicines and vaccines are increasingly treated as strategic assets, not just commercial products. That shift matters for South Africa, which still relies heavily on imports for...
South Africa has launched its first-ever human HIV vaccine trial. It is a landmark for a country that remains the global epicentre of HIV. The long-term ambition is clear. Scientists want a safe, affordable vaccine given in the first year of life, with no need for...
Twenty-twenty-six is shaping up as a year of sharp policy fights, fast-moving science, and stubborn system failures. Spotlight’s 2026 Healthcare Watchlist will track nine stories that could shift budgets, reshape services, and test public trust. A limited rollout of a...
South Africa stands at a pivotal moment in its long battle against HIV. While the country has made remarkable strides since the mass rollout of antiretrovirals, boosting rural life expectancy by over 10 years, a new medical innovation could accelerate progress even...
International health activists and civil society organisations have launched a scathing critique of pharmaceutical giant Gilead Sciences and the US government. They say that Lenacapavir is in short supply and woefully inadequate to slow Africa’s epidemic. The...
